News | Radiation Therapy | May 20, 2016

Elekta Surpasses 1 Million Patients Treated with Leksell Gamma Knife

Latest iteration of stereotactic and radiation therapy platform to be installed at five new sites in coming months

May 20, 2016 — At the 18th International Leksell Gamma Knife Society Meeting in Amsterdam, May 15-19, Elekta announced the Leksell Gamma Knife radiosurgery system has been used in the treatment of more than 1 million patients. The system has been used on patients afflicted with brain tumors, vascular malformations and functional disorders.

Today, Gamma Knife surgery is performed on more than 75,000 patients every year in hundreds of hospitals and clinics around the world. The average clinical volume per treatment site has also steadily grown each year due to a proliferation of supporting clinical evidence and product enhancements that improve clinical efficiency.

Leksell Gamma Knife Icon, the newest generation of the system, is currently being used to treat patients in Europe, the United States and Asia. Icon expands on the capabilities of Gamma Knife, while providing additional frameless flexibility for either accurate single-dose administration or fractionated multiple treatment sessions over time, enabling treatment of larger tumor volumes, targets close to critical brain structures and new or recurring brain metastases.

In the coming months, installations of Icon are planned at several leading centers including The University of Texas MD Anderson Cancer Center (Houston), University of Pittsburgh Medical Center (Pittsburgh), University of Virginia Health System (Charlottesville, Va.), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, Netherlands) and Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland).

Metastatic brain tumors and other neurological disorders negatively impact survival and quality of life in a large and growing patient population. Worldwide, more than 256,000 new cases of brain and other central nervous system (CNS) tumors are diagnosed annually, with an estimated 189,000 deaths.

“Gamma Knife radiosurgery is a proven approach that has helped us resolve complex brain lesions, vascular complications and other neurological abnormalities, many of which were previously thought to be inoperable,” said Jean Regis, M.D., neurosurgeon and Gamma Knife program director, University Hospital La Timone, Marseille, France, who has performed more than 16,000 Gamma Knife procedures. “Over the past four decades, we’ve established a wide body of clinical evidence supporting Gamma Knife radiosurgery in the treatment of diverse brain and central nervous system pathologies, and in my experience, this is an attractive option for patients and clinicians, enabling a significant reduction in radiation exposure to healthy tissue and a negligible post-procedural convalescence period where the typical patient can usually leave the hospital within an hour.”

Douglas Kondziolka, M.D., a researcher and neurosurgeon who has performed many thousands of Gamma Knife procedures, added “Gamma Knife radiosurgery is an excellent example of how evolving cancer care technologies are addressing growing demand for precision medicine, where treatments can be precisely tailored to an individual’s unique anatomy and biologic makeup while simultaneously helping to reduce the risk of damaging healthy tissue. As one of the most comprehensively studied tools in the neurosurgery armamentarium, we can confidently offer this treatment option as a minimally invasive alternative to traditional brain surgery or whole brain radiation therapy for properly selected patients.”

“Receiving a brain tumor diagnosis is nothing short of shocking, but I feel incredibly fortunate to have discovered an effective alternative to traditional open surgery,” said Josh Perry, 27-year-old pro BMX athlete who underwent an open craniotomy for a meningioma and then received Gamma Knife to treat a recurrence several years later. “In contrast to my first procedure, which took six hours and required a two month recovery, I was up and talking minutes after receiving Gamma Knife and back on my bike within a week.”

Stereotactic radiosurgery is a non-invasive alternative to traditional brain surgery and radiation therapy for the treatment of complex, difficult to treat brain conditions. Using up to 192 precisely focused sources of radiation, Gamma Knife controls malignant and nonmalignant tumors, as well as arteriovenous malformations, essential tremor and trigeminal neuralgia while limiting damage to healthy tissue. The extremely high precision of Gamma Knife surgery is achieved using a three-dimensional coordinate system to locate and treat small targets inside the head.

For more information: www.gammaknife.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...